Varenicline Kit
Product Images NDC 33342-577

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Varenicline (NDC 33342-577). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

222 (Varenicline Tab Fig 1)

A bar chart titled "Figure 1: Continuous Abstinence, Weeks 9 through 12" comparing the percentage of continuous abstinence among subjects treated with Varenicline tablets at doses of 0.5 mg and 1 mg twice daily (BID), versus placebo. The chart includes data from multiple studies (Study 2, Study 3, Study 4, and Study 5) showing higher abstinence rates with Varenicline compared to placebo.*

FDA Label Image

333 (Varenicline Tab Fig 2)

A bar chart titled 'Continuous Abstinence, Weeks 9 through 52' comparing different formulations of varenicline tablets (TID, BID, ER) against placebo across studies 2 to 5. The y-axis represents percentage abstinence with error bars, showing higher rates for varenicline treatments compared to placebo in each study.*

FDA Label Image

444 (Varenicline Tab Fig 3)

A line graph titled "Continuous Abstinence Rate during Nontreatment Follow-Up" comparing Varenicline Tablets 1.0 mg twice daily versus placebo. The y-axis represents the percentage continuous abstinent, and the x-axis shows nontreatment follow-up time in weeks. The graph depicts a higher abstinence rate for Varenicline compared to placebo over time.*

FDA Label Image

111 (Varenicline Tab Structure)

Chemical structure of the active ingredient Varenicline, showing its molecular framework including fused rings and functional groups, presented in a 2D diagram.*

FDA Label Image

776 (Varenicline Tablets 05mg 56s)

Label for Varenicline Tablets 0.5 mg, oral film-coated tablets manufactured for Macleods Pharma USA, Inc. The label includes storage instructions, dosage information note, and states the package contains 56 tablets. The label displays manufacturer information for Macleods Pharmaceuticals Ltd., India, with an NDC barcode and mentions a medication guide availability online.*

FDA Label Image

114 (Varenicline Tablets 1mg 56s)

Label for Varenicline Tablets 1 mg manufactured by Macleods Pharmaceuticals Limited, featuring Macleods Pharma USA as distributor. The label indicates 56 film-coated oral tablets with instructions to always dispense with a medication guide. Storage conditions and dosage references are included, along with barcode and NDC 33342-490-19.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.